Capital International Investors’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,418,602
| Closed | -$334M | – | 443 |
|
|
2024
Q4 | $334M | Sell |
1,418,602
-2,552,261
| -64% | -$601M | 0.06% | 190 |
|
|
2024
Q3 | $1.09B | Buy |
3,970,863
+79,804
| +2% | +$21.9M | 0.21% | 107 |
|
|
2024
Q2 | $946M | Buy |
3,891,059
+239,842
| +7% | +$58.3M | 0.19% | 109 |
|
|
2024
Q1 | $546M | Buy |
3,651,217
+64,560
| +2% | +$9.65M | 0.11% | 156 |
|
|
2023
Q4 | $687M | Buy |
3,586,657
+488,814
| +16% | +$93.6M | 0.15% | 132 |
|
|
2023
Q3 | $549M | Buy |
3,097,843
+217,200
| +8% | +$38.5M | 0.14% | 147 |
|
|
2023
Q2 | $547M | Buy |
2,880,643
+651,054
| +29% | +$124M | 0.13% | 158 |
|
|
2023
Q1 | $447M | Buy |
2,229,589
+223,968
| +11% | +$44.9M | 0.11% | 168 |
|
|
2022
Q4 | $477M | Buy |
2,005,621
+58,907
| +3% | +$14M | 0.13% | 164 |
|
|
2022
Q3 | $390M | Buy |
1,946,714
+312,477
| +19% | +$62.5M | 0.11% | 174 |
|
|
2022
Q2 | $238M | Buy |
+1,634,237
| New | +$238M | 0.06% | 229 |
|